GreenStocksOnline.com: GreenCell, Inc. (OTCBB: GCLL) Announces Low Cost Fuel Stack Design

   GreenCell, Inc. (OTCBB: GCLL), a company that develops, commercializes and markets UltraTemp™ ceramic composite materials for home and transportation applications, has recently announced that they have developed the technology with their UltraTemp-C property to make a safer and easier the maintain fuel cell that produces a cheaper kilowatt, giving the user a low overall cost of ownership.

UltraTemp™, a ceramic composite material based upon ceramic fiber/ceramic matrix combinations, bridges a gap left by current products. It has virtually endless uses, but is being targeted initially by GreenCell for igniters, oxygen sensors and fuel cells. According to Global Industry Analysts, Inc., Solid Oxide Fuel Cells (SOFC) are estimated to reach $240.6 million a year globally by 2015, driven by SOFCs holding enormous potential for low cost, and clean energy/electricity generation from currently available fossil fuels.

To read more on GreenCell, Inc., please visit www.greenstocksonline.com

Other active stocks are Great Wall Builders (OTCBB: GWBU), SEFE, Inc (OTCBB: SEFE) and Facebook (NASDAQ: FB)

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid OTC Report one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. In light of the above, we accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

OTC Report Email Contact